Skip to main content
OpenTrials

Clinical trial condition

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis

Explore clinical trials studying Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis trial results

Recruiting

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

NCT06318169

Conditions
Digestive System Diseases, Fatty Liver, Fibrosis, +7 more
Locations
  • 89bio Clinical Study Site Birmingham, Alabama, United States
  • 89bio Clinical Study Site Chandler, Arizona, United States
  • 89bio Clinical Study Site Flagstaff, Arizona, United States
  • 89bio Clinical Study Site Glendale, Arizona, United States
View all 361 locations
View Trial Details

Related conditions